Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 976 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Endothelial Clear all

Conditions: Atherosclerosis, Peripheral Vascular Disease
Interventions: Magnetic resonance imaging; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Liver Cancer
Interventions: Sunitinib Malate; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Diabetes Mellitus, Type 2, Insulin Response, Endothelial Dysfunction
Interventions: Tauroursodeoxycholic acid; Dietary Supplement
Lead sponsor: Boston University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension in Pregnancy
Interventions: Docosahexaenoic acid 200 mg, Docosahexaenoic acid 1000 mg; Dietary Supplement · Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms
Interventions: Vandetanib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sedentary Lifestyle
Interventions: Frequent sit-to-stands, Walking breaks, Stand more; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 55 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Heart Transplantation
Interventions: Bradykinin; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Coronary Artery Disease
Interventions: Questionnaire of overall health; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 50 Years and older · Female only
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Covid19-associated ARDS, Covid19, ARDS
Interventions: AV-001, Placebo; Drug · Other
Lead sponsor: Vasomune Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Aging
Interventions: Niagen™, Placebo; Dietary Supplement
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 55 Years to 79 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Fuchs Endothelial Corneal Dystrophy
Interventions: N-acetyl cysteine (NAC) 10% solution, N-acetyl cysteine (NAC) 20% solution, Visine Dry Eye Relief eye drops; Drug
Lead sponsor: Massachusetts Eye and Ear Infirmary; Other
Eligibility: 21 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vascular Anomaly, Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma, Kaposiform Lymphangiomatosis, Gorham-Stout Disease, Klippel Trenaunay Syndrome, Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 1 Day and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2050
U.S. locations: 2
States / cities: Boston, Massachusetts • Cincinnati, Ohio

Conditions: Sickle Cell Disease
Interventions: Sapropterin Dihydrochloride; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 15 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 12
States / cities: Washington D.C., District of Columbia • Augusta, Georgia • Savannah, Georgia + 9 more

Conditions: Microgravity Exposed Endothelial Cells
Interventions: Blood volume collected specifically for this study; Biological
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 50 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Chronic Kidney Disease, Cardiovascular Disease
Interventions: Lanthanum carbonate, placebo, Ascorbic Acid, Nitroglycerin, Flow-mediated dilation measurement, Aortic pulse-wave velocity, Endothelial cell collection; Drug · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 79 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Coronary Artery Disease (CAD)
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years and older
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2006
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Disease, Type 2 Diabetes
Interventions: Not listed
Lead sponsor: Ohio State University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Endothelial Function of Saphenous Vein Grafts
Interventions: Use of Maquet Vasoshield Pressure-limiting syringe on SVG, Use of non-regulated syringe on SVG; Other
Lead sponsor: Emory University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Diabetes
Interventions: Walnut Ad libitum diet, Walnut Calorie controlled; Dietary Supplement
Lead sponsor: Griffin Hospital; Other
Eligibility: 25 Years to 75 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Derby, Connecticut

Conditions: Endothelial Dysfunction, Inflammation, Oxidative Stress
Interventions: Traditional hookah smoking, Electronic hookah vaping; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years to 39 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Blood Pressure
Interventions: L-citrulline, Placebo; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 14 Years to 40 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fuchs
Interventions: Topical Ripasudil, Topical Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Palo Alto, California • Sacramento, California • Palm Beach Gardens, Florida + 3 more

Conditions: Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2020
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Renal Insufficiency, Chronic
Interventions: Rilonacept, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Aurora, Colorado • Nashville, Tennessee

Search by objective public record fields.

Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Effects of TUDCA on Endothelial Function in Type 2 DM

Docosahexaenoic Acid Supplementation of Women With Hypertension in Pregnancy to Improve Endothelial Health

Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Sedentary Behavior Interrupted - A Pilot Study of Acute Interventions on Prolonged Sitting

Brachial Artery t-PA Release in Heart Transplant Recipients

Uric Acid Levels and Endothelial Functions

A First-in-Human Study of AV-001 in Healthy Subjects

Safety & Efficacy of Nicotinamide Riboside Supplementation for Improving Physiological Function in Middle-Aged and Older Adults

Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy

Identification of Biomarkers for Patients with Vascular Anomalies

A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease

Microgravity Effects on Co-cultured Vascular Cells Types

Phosphate Lowering in CKD Trial

Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants

Complement and Cardiovascular Risk in Adolescents

Investigation of Endothelium in Saphenous Vein Grafts

Walnut Ingestion in Adults at Risk for Diabetes: Effects on Body Composition, Diet Quality, and Cardiac Risk Measures

The Cardiovascular Effects of Electronic Hookah Vaping

Oral L-Citrulline and ADMA in Pregnancy

Descemet Endothelial Thickness Comparison Trial I

Study of Venous Endothelial Cells in Rheumatoid Arthritis

Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)